Skip to content

Impact of kestose on the gut microbiota in patients after gastrectomy

Impact of kestose on the gut microbiota in patients after gastrectomy - Impact of kestose on the gut microbiota in patients after gastrectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs041260002
Enrollment
50
Registered
2026-04-02
Start date
2026-04-02
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer Gut microbiome

Interventions

Participants will be allocated to either a kestose intake group or a non-intake (control) group. In the kestose intervention group, oral administration of kestose at a dose of 6 g/day will be initiate
C072433

Sponsors

Suda Koichi
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients who have provided written informed consent to participate in this study after receiving a full explanation of the study. 2. Patients aged 20 years or older and younger than 90 years at the time of obtaining informed consent. 3. Patients with a pathological diagnosis of gastric cancer who are scheduled to undergo distal or total gastrectomy at Fujita Health University Hospital.

Exclusion criteria

Exclusion criteria: 1. History of small or large bowel resection (appendectomy permitted). 2. Receipt of preoperative chemotherapy. 3. Regular use of probiotics or gastrointestinal agents (gut-modulating agents) prior to surgery. 4.Severe constipation likely to preclude stool sample collection. 5.Any other condition that, in the opinion of the principal investigator or sub-investigators, renders the patient unsuitable for participation in the study.

Design outcomes

Primary

MeasureTime frame
Change from baseline in the proportion of short-chain fatty acid-producing bacteria in the gut microbiota at 3 months after gastrectomy

Secondary

MeasureTime frame
1. Percentage of body weight loss at 3 months after gastrectomy 2. Clinical nutritional parameters at 3 months after gastrectomy, including serum albumin, prealbumin, cholesterol, cholinesterase, and related markers Association between the gut microbiota and post-gastrectomy syndrome Proportion of short chain fatty acid producing bacteria at 12 months postoperatively (change from baseline) Percentage of body weight loss at 12 months postoperatively Sarcopenia and body composition assessment (at 3, 6, and 12 months postoperatively)

Contacts

Public ContactTsuyoshi Tanaka

Department of Surgery, Fujita Health University Hospital

tys-tnk@umin.ac.jp+81-562-93-9254

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026